Blaauboer B J
Institute for Risk Assessment Sciences, Division of Toxicology, Utrecht University, P.O. Box 80.176, 3508 TD Utrecht, The Netherlands.
Toxicol Lett. 2003 Feb 18;138(1-2):161-71. doi: 10.1016/s0378-4274(02)00367-3.
Toxicity of a compound for an organism is dependent on the route of exposure, the amount (or concentration), the way in which the compound is taken up, distributes and is eliminated from the organism (ADME, kinetics) and the intrinsic properties (reactivity; mode of action, dynamics) of the compound towards the organism. These three elements: exposure, kinetics and dynamics form the basis of hazard and risk evaluations. Developments in our knowledge of the way in which physico-chemical properties of chemicals (on the one side) and physiological processes in the organism (on the other side) determine a compound's toxicity have greatly increased our understanding of toxicological processes and our ability to interpret experimental results. This has now resulted in the development of model systems in which the above-mentioned processes can be described mathematically. Biokinetic modelling is currently of great interest, but the further development of toxicodynamic modelling is equally important. The combination of both allows the estimation of a compound's critical amount/concentration on the critical site of action, which ideally would be the basis for hazard and risk assessments. In vitro systems have been extremely useful in studying the molecular basis of a chemical's biological activity, including its mechanism(s) of toxic action. Other achievements include the prediction of biological reactivity on the basis of a compound's physico-chemical properties and the construction of quantitative structure-activity relationships (QSARs). However, for the incorporation of in vitro-derived data as well as the results of QSARs, kinetic modelling is indispensable. Thus, biokinetic and toxicodynamic modelling are important (if not crucial) tools in toxicological research and there are increasing opportunities to incorporate the results of this work in hazard and risk assessments. Their implementation will allow a much more scientifically-based and a better structured risk assessment, which will be to a much lesser extent relying on animal experimentation.
一种化合物对生物体的毒性取决于接触途径、数量(或浓度)、化合物被生物体吸收、分布和消除的方式(ADME,动力学)以及该化合物对生物体的内在特性(反应性;作用方式、动力学)。这三个要素:接触、动力学和动力学构成了危害和风险评估的基础。我们对化学物质的物理化学性质(一方面)和生物体中的生理过程(另一方面)如何决定化合物毒性的认识发展,极大地增进了我们对毒理学过程的理解以及我们解释实验结果的能力。这现已导致开发出能够用数学方式描述上述过程的模型系统。生物动力学建模目前备受关注,但毒效动力学建模的进一步发展同样重要。两者结合可估算化合物在关键作用部位的临界量/浓度,理想情况下这将成为危害和风险评估的基础。体外系统在研究化学物质生物活性的分子基础,包括其毒作用机制方面极其有用。其他成果包括根据化合物的物理化学性质预测生物反应性以及构建定量构效关系(QSARs)。然而,要纳入体外衍生数据以及QSARs的结果,动力学建模是必不可少的。因此,生物动力学和毒效动力学建模是毒理学研究中的重要(甚至关键)工具,并且将这项工作的结果纳入危害和风险评估的机会越来越多。它们的实施将使风险评估更具科学性和更好的结构性,在很大程度上减少对动物实验的依赖。